Clinical Trial: The effectiveness of a personalized digital health intervention for improving adherence to adjuvant endocrine therapy in women with breast cancer (P-DAAC) (China)

Posted On: 2026-09-21

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effectiveness of a personalized digital health intervention for improving adherence to adjuvant endocrine therapy in women with breast cancer (P-DAAC)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132888

Registration Time: 2026/09/20

Type: Interventional study

Primary Sponsor: Xiangya School of Nursing of Central South University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343533

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: The effectiveness of a personalized digital health intervention for improving adherence to adjuvant endocrine therapy in women with breast cancer (P-DAAC) (China)